Bio Essence (BIOE) Cost of Revenue (2020 - 2026)

Bio Essence's Cost of Revenue history runs 7 years deep, the most recent figure standing at $680.0 for Q1 2026.

• In Q1 2026, Cost of Revenue rose 25.23% year-over-year to $680.0; the TTM figure through Mar 2026 stood at -$10718.0 (down 109.98% YoY), while the FY2025 annual figure was $30593.0, down 71.37% from the prior year.
• Cost of Revenue was $680.0 for Q1 2026 at Bio Essence, up from -$102527.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $173299.0 in Q1 2023 to a low of -$410559.0 in Q4 2023.
• Historically, Cost of Revenue has averaged -$17390.2 across 5 years, with a median of $12508.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue slumped 2223.29% in 2022, then surged 1532.74% in 2023.
• A 5-year view of Cost of Revenue shows it stood at -$395973.0 in 2022, then dropped by 3.68% to -$410559.0 in 2023, then surged by 109.9% to $40657.0 in 2024, then slumped by 352.18% to -$102527.0 in 2025, then jumped by 100.66% to $680.0 in 2026.
• The last three Cost of Revenue figures came in at $680.0 (Q1 2026), -$102527.0 (Q4 2025), and $650.0 (Q3 2025), per Business Quant data.